The ABPI Code of Practice, explained for marketers
A plain-language guide to the parts of the ABPI Code that shape pharmaceutical marketing copy in the UK — fair balance, substantiation, audience rules and the mandatory information every promotional asset has to carry.
What this page is. A marketing orientation to the ABPI Code of Practice for the Pharmaceutical Industry, written for people who brief, write and review copy. It is not legal, medical or regulatory advice, and it does not replace the Code itself, your company SOPs, or your medical, legal and regulatory review. Always work from the current published Code and your own approved product information.
What the Code covers
The Code is the UK pharmaceutical industry's self-regulatory framework for the promotion of prescription medicines and for interactions with health professionals, patients and the public. These are the areas that change how copy is written.
High standards and the spirit of the Code
The Code asks for more than technically accurate copy. Material must maintain high standards, never bring discredit on the industry, and be judged on the impression it creates overall — not on whether each sentence can be defended in isolation.
Practical read: if a post reads as hype when you step back from it, the individual claims being referenced will not save it in review.
Accuracy, balance and fair balance
Claims must be accurate, balanced, fair and capable of substantiation. Safety information carries the same prominence as efficacy — that is what fair balance means in practice, and it applies per asset rather than per campaign.
Practical read: an efficacy claim and its safety information belong in the same asset. A linked thread, a second slide or a landing page does not close the gap.
Substantiation and references
Every claim must be substantiable at the moment it is made, consistent with the current summary of product characteristics, and supported by evidence you can produce if challenged.
Practical read: build the reference block while you write the copy, not after MLR asks for it.
HCP versus public audiences
Promotion of prescription-only medicines is permitted to health professionals and prohibited to the public. On digital channels the audience is defined by who can see the material, not who you intended to reach.
Practical read: open social accounts and untargeted paid media are public. Disease awareness for the public must not identify a specific medicine.
Prescribing information and mandatory statements
Promotional material for health professionals carries prescribing information, the non-proprietary name, an adverse event reporting statement and, where applicable, black triangle and prescribing-information access details.
Practical read: treat the mandatory block as part of the layout from the first draft. Retrofitting it is what breaks character counts and designs.
The PMCPA and complaints
The Prescription Medicines Code of Practice Authority administers the Code and publishes case reports. Rulings are public, name the company, and are the clearest picture of where teams actually get caught out.
Practical read: published cases are free training material. Most concern balance, audience and unsubstantiated superiority claims.
What each asset type needs to carry
A quick orientation to where fair balance, references and audience restrictions apply. Confirm the detail against the current Code and your own SOPs before you publish.
| Asset | Fair balance | References | Audience |
|---|---|---|---|
| HCP email or detail aid | Yes — safety alongside every efficacy claim | Yes — full references plus prescribing information | Health professionals only |
| Organic social post (HCP) | Yes — in the same post, not a reply or thread | Yes — plus a route to prescribing information | Only where HCP restriction genuinely holds |
| Paid social (HCP-targeted) | Yes — including within truncated previews | Yes — and targeting evidence retained | HCP-verified targeting required |
| Public disease awareness | Balanced information, no promotional claims | Sources for factual claims | Public — must not identify a medicine |
| Patient support material | Yes — risks stated plainly | Approved sources only | Patients already prescribed the medicine |
Go deeper on a specific area
- Writing ABPI-compliant social media copyChannel-by-channel rules for LinkedIn, X, Instagram and reshares.
- HCP versus public audience rulesWhere the line sits on digital channels and how to stay on the right side of it.
Working on social specifically? Use the ABPI social media compliance checklist before your next post enters review.